
脂肪原/硼霉素/AG-CN2-0166-M001/1 mg
商品编号:
AG-CN2-0166-M001
品牌:
Adipogen Inc
市场价:
¥6000.00
美元价:
3600.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product Details | |
---|---|
Synonyms | Antibiotic A 28829; Ivomycin; NSC216128 |
Product Type | Chemical |
Properties | |
Formula | C45H74BNO15 |
MW | 879.9 |
CAS | 34524-20-4 |
Source/Host Chemicals | Isolated from Streptomyces sp. |
Purity Chemicals | ≥99% (TLC) |
Appearance | Off-white solid. |
Solubility | Soluble in DMSO, ethanol or methanol. |
Declaration | Manufactured by BioLinks K.K. with courtesy strain from The Kitasato Institute. |
InChi Key | OOBFYEMEQCZLJL-UWTAGDQBSA-O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability |
Stable for at least 2 years after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
MSDS |
![]() |
Product Specification Sheet | |
Datasheet |
![]() |
- Boron-containing macrolide antibiotic [1].
- Antibacterial [1].
- Antiprotozoal (Plasmodium, Babesia) [2].
- Anti-HIV compound [3,6].
- Ca2+ homeostasis modulator [4].
- Potentiator of bleomycin-induced anti-tumor activity [5].
- Used as a chiral selector in capillary electrophoresis [7].
Product References
- Structure of boromycin: J.D. Dunitz, et al.; Helv. Chim. Acta 54, 1709 (1971)
- Antibiotic A 28829: V. Prelog, et al.; US Patent 3,769,418 (1973)
- Boromycin, an anti-HIV antibiotic: J. Kohno, et al.; Biosci. Biotechnol. Biochem. 60, 1036 (1996)
- The effect of boromycin on the Ca2+ homeostasis: B. Lakatos, et al.; Mol. Cell Biochem. 231, 15 (2002)
- Boromycin abrogates bleomycin-induced G2 checkpoint: M. Arai, et al.; J. Antibiot. 57, 662 (2004)
- Biologically active compounds of semi-metals: T. Rezanka & K. Sigler; Phytochem. 69, 585 (2008) (Review)
- Study on the use of boromycin as a chiral selector in capillary electrophoresis: V. Maier, et al.; J. Chromatogr. A. 1237, 128 (2012)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们